The fifth protease inhibitor, Agenerase (amprenavir)
May 1999
The fifth protease inhibitor, Agenerase (amprenavir), will soon hit the market...from Glaxo Wellcome.
It will be used in combo therapy with other HIV antiretrovirals.
The usual adult dose is 1200 mg (8 capsules) BID.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote